Prestige Brands Acquires C.B. Fleet, Boosts Women’s OTC Platform
This article was originally published in The Pink Sheet
Executive Summary
Prestige Brands makes the deal three weeks after divesting the slower-selling Massengill douche brand and as it makes a top marketing priority of growing sales of its Monistat yeast treatment line.
You may also be interested in...
Moberg Adds DermoPlast Line With Bondholders' Blessing For More
Moberg says sales of DermoPlast sprays were $12m in the 12 months through September and its purchase price is around 8.9 times the estimated EBITDA for the brand during the period.
DenTek Deal Expands Prestige Brands’ Oral Care Portfolio, OTC Focus
While overall oral care sales grow 2.4% in the 52-week period through Oct. 3, sales of the sub-category of floss picks, dental guards, interdental brushes, disposable picks, dental wax, floss threaders, dental picks and tongue cleaners grew 9%. DenTek is first in floss pick sales and second in interdental brush sales.
Prestige Brands Visits Doctors To Cure Slumping Monistat Sales
The firm in the second half of 2015 plans six initiatives to influence health care professionals on recommending Monistat for patients, CEO Matthew Mannelly says. Sales of Monistat have slid since a previous owner of the brand stopped marketing to health care professionals.